Classical Monocytes Shuttling for Precise Delivery of Nanotherapeutics to Glioblastoma
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202400925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Congwen Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Glioblastoma, Monocytes, Brain Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science Fund for Creative Research Groups.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most aggressive brain tumor for which current therapies have limited efficacy. Immunosuppression and difficulties in accessing tumors with therapeutic agents are major obstacles for GBM treatments. Classical monocytes (CMs) possess the strongest infiltration among myeloid cells recruited into tumors during tumorigenesis. In this study, CMs are utilized to deliver the small‐molecule CUDC‐907 encapsulated in nanoparticles (907‐NPs@CMs) for GBM therapy. Hitchhiking on CMs enables more 907‐NPs to successfully penetrate the blood–brain barrier (BBB) and reach the interior of tumors. Results demonstrate that 907‐NPs@CMs significantly improve the survival rates by suppressing tumor growth and reversing the immunosuppression of tumor microenvironment (TME). Furthermore, the high delivery efficiency of CMs reduces the amount of CUDC‐907 required for treatments, reducing the physiological toxicity and off‐target effects caused by high doses. 907‐NPs@CMs is a safe and versatile therapeutic system that provides a platform for targeted drug delivery to tumors and the ability to treat GBM through a combination of chemotherapy and immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
- Department of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai, 200032, China.
- Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
- Shanghai Fifth People's Hospital, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Science, Fudan University, Shanghai, 200030, China.
- Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
- MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases, Fudan University, Shanghai, 200032, China.
ORCID-Profile: Yiwei Chu
Förderung
- National Natural Science Foundation of China
- Science Fund for Creative Research Groups
Zitieren
APA
Li, C., Niu, C., Chen, L., Yu, B., Luo, F., Qie, J., Yang, H., Qian, J., & Chu, Y. (2024). Classical Monocytes Shuttling for Precise Delivery of Nanotherapeutics to Glioblastoma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202400925
Vancouver
Li C, Niu C, Chen L, Yu B, Luo F, Qie J, et al. Classical Monocytes Shuttling for Precise Delivery of Nanotherapeutics to Glioblastoma. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202400925
BibTeX
@article{Li2024,
author = {Li, Congwen and Niu, Congyi and Chen, Lin and Yu, Baichao and Luo, Feifei and Qie, Jingbo and Yang, Hui and Qian, Jiawen and Chu, Yiwei},
title = {Classical Monocytes Shuttling for Precise Delivery of Nanotherapeutics to Glioblastoma},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202400925}
}
EUVIMED